116 related articles for article (PubMed ID: 3081282)
21. Comparison of plasminogen activator inhibitor activity and antigen in plasma samples.
Urdén G; Hamsten A; Wiman B
Clin Chim Acta; 1987 Nov; 169(2-3):189-96. PubMed ID: 3501347
[TBL] [Abstract][Full Text] [Related]
22. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef RR; Higgins DL; Pillemer E; Levitt LJ
J Clin Invest; 1989 May; 83(5):1747-52. PubMed ID: 2496147
[TBL] [Abstract][Full Text] [Related]
23. A plasmin generation method for the determination of tissue plasminogen activator (t-PA) activity in blood.
Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
Immunol Cell Biol; 1989 Jun; 67 ( Pt 3)():197-203. PubMed ID: 2529206
[TBL] [Abstract][Full Text] [Related]
24. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
Colucci M; Paramo JA; Stassen JM; Collen D
J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycle.
Jespersen J; Kluft C
Thromb Haemost; 1986 Jun; 55(3):388-9. PubMed ID: 3092396
[TBL] [Abstract][Full Text] [Related]
26. Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: a novel principle.
Stief TW; Lenz P; Becker U; Heimburger N
Thromb Res; 1988 May; 50(4):559-73. PubMed ID: 3137681
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.
Colucci M; Paramo JA; Collen D
J Lab Clin Med; 1986 Jul; 108(1):53-9. PubMed ID: 3086473
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
Urdén G; Johansson U; Chmielewska J; Brandt J; Wiman B
Thromb Haemost; 1986 Jun; 55(3):383-7. PubMed ID: 3092395
[TBL] [Abstract][Full Text] [Related]
29. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
[TBL] [Abstract][Full Text] [Related]
30. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
31. [Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke].
Han XM; Chen ZQ; Mao HM
Zhonghua Nei Ke Za Zhi; 1990 Sep; 29(9):544-6, 575-6. PubMed ID: 2128260
[TBL] [Abstract][Full Text] [Related]
32. Impaired fibrinolysis in coronary artery disease.
Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
[TBL] [Abstract][Full Text] [Related]
33. Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.
Carr ME; Krishnamurti C; Alving BM
Thromb Haemost; 1992 Jan; 67(1):106-10. PubMed ID: 1615464
[TBL] [Abstract][Full Text] [Related]
34. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.
Mehta J; Mehta P; Lawson D; Saldeen T
J Am Coll Cardiol; 1987 Feb; 9(2):263-8. PubMed ID: 3100598
[TBL] [Abstract][Full Text] [Related]
35. Presence of a fast-acting specific inhibitor of plasminogen activator in human parotid saliva.
Kjaeldgaard A; Kjaeldgaard M; Gaffney P
Acta Physiol Scand; 1989 Nov; 137(3):379-83. PubMed ID: 2512768
[TBL] [Abstract][Full Text] [Related]
36. Optimum conditions for the stabilization and measurement of tissue plasminogen activator activity in human plasma.
Chandler WL; Schmer G; Stratton JR
J Lab Clin Med; 1989 Mar; 113(3):362-71. PubMed ID: 2494279
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator inhibitor activity in bacterial infection.
Páramo JA; Fernández Diaz FJ; Rocha E
Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
[TBL] [Abstract][Full Text] [Related]
38. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
[TBL] [Abstract][Full Text] [Related]
40. Serpin-resistant mutants of human tissue-type plasminogen activator.
Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF
Nature; 1989 Jun; 339(6227):721-4. PubMed ID: 2500599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
